CMAJ • March 17, 2009; 180 (6). doi:10.1503/cmaj.080972.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Online Appendices
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ley, S. H.
Right arrow Articles by Hanley, A. J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ley, S. H.
Right arrow Articles by Hanley, A. J.G.
Related Collections
Right arrow Screening tests
Right arrow Diabetes
Right arrow Aboriginal Health
Right arrowRelated Articles

Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community

Sylvia H. Ley, RD MSc, Stewart B. Harris, MD, Mary Mamakeesick, RPN, Tina Noon, Edith Fiddler, Joel Gittelsohn, PhD, Thomas M.S. Wolever, MD PhD, Philip W. Connelly, PhD, Robert A. Hegele, MD, Bernard Zinman, MD and Anthony J.G. Hanley, PhD

From the Department of Nutritional Sciences (Ley, Wolever, Hanley), University of Toronto, Toronto, Ont.; the Center for Studies in Family Medicine (Harris), Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ont.; the Sandy Lake Health and Diabetes Project (Mamakeesick, Noon, Fiddler), Sandy Lake, Ont.; the Center for Human Nutrition (Gittelsohn), Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; the Department of Laboratory Medicine and Pathobiology (Connelly), University of Toronto, Toronto, Ont.; the Keenan Research Centre of the Li Ka Shing Knowledge Institute (Connelly); St. Michael's Hospital, Toronto, Ont.; the Robarts Research Institute and University of Western Ontario (Hegele), London, Ont.; the Division of Endocrinology (Zinman, Hanley), University of Toronto, Toronto, Ont.; the Leadership Sinai Centre for Diabetes (Zinman, Hanley), Mount Sinai Hospital, Toronto, Ont.; and the Samuel Lunenfeld Research Institute (Zinman), Mount Sinai Hospital, Toronto, Ont.


Figure 112
View larger version (28K):
[in this window]
[in a new window]

  		Figure 1: Eligibility and participation in the Sandy Lake Health and Diabetes Project follow-up study.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

Figure 212
View larger version (23K):
[in this window]
[in a new window]

  		Figure 2: Age- and sex-adjusted risk of type 2 diabetes associated with readily accessible clinical measurements.

 

View this table:
[in this window]
[in a new window]

  		Table 2.

 

Figure 312
View larger version (11K):
[in this window]
[in a new window]

  		Figure 3: Age- and sex-adjusted risk of type 2 diabetes associated with impaired glucose tolerance and with metabolic syndrome. C statistics for metabolic syndrome, whether defined by the National Cholesterol Education Program criteria (0.668) or the International Diabetes Federation criteria (0.682), were not significantly different from the C statistic for impaired glucose tolerance (0.681) (p > 0.05 for comparisons of C statistics).